Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | ||
---|---|---|---|---|---|---|
Current ratio | 2.05 | 1.71 | 1.69 | 1.95 | 1.78 | |
Quick ratio | 1.58 | 0.95 | 0.96 | 1.20 | 1.10 | |
Cash ratio | 1.28 | 0.48 | 0.46 | 0.69 | 0.60 |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Baxter International Inc. current ratio improved from 2013 to 2014 and from 2014 to 2015. |
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Baxter International Inc. quick ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level. |
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Baxter International Inc. cash ratio improved from 2013 to 2014 and from 2014 to 2015. |
Current Ratio
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Current assets | 11,796) | 10,351) | 10,004) | 9,260) | 8,650) | |
Current liabilities | 5,750) | 6,042) | 5,906) | 4,759) | 4,857) | |
Liquidity Ratio | ||||||
Current ratio1 | 2.05 | 1.71 | 1.69 | 1.95 | 1.78 | |
Benchmarks | ||||||
Current Ratio, Competitors2 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Cigna Group | — | — | — | — | — | |
CVS Health Corp. | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Current ratio = Current assets ÷ Current liabilities
= 11,796 ÷ 5,750 = 2.05
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Baxter International Inc. current ratio improved from 2013 to 2014 and from 2014 to 2015. |
Quick Ratio
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Cash and equivalents | 2,213) | 2,925) | 2,733) | 3,270) | 2,905) | |
Accounts and other current receivables, net | 1,731) | 2,803) | 2,911) | 2,425) | 2,420) | |
Investment in Baxalta common stock | 5,148) | —) | —) | —) | —) | |
Total quick assets | 9,092) | 5,728) | 5,644) | 5,695) | 5,325) | |
Current liabilities | 5,750) | 6,042) | 5,906) | 4,759) | 4,857) | |
Liquidity Ratio | ||||||
Quick ratio1 | 1.58 | 0.95 | 0.96 | 1.20 | 1.10 | |
Benchmarks | ||||||
Quick Ratio, Competitors2 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Cigna Group | — | — | — | — | — | |
CVS Health Corp. | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 9,092 ÷ 5,750 = 1.58
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Baxter International Inc. quick ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level. |
Cash Ratio
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Cash and equivalents | 2,213) | 2,925) | 2,733) | 3,270) | 2,905) | |
Investment in Baxalta common stock | 5,148) | —) | —) | —) | —) | |
Total cash assets | 7,361) | 2,925) | 2,733) | 3,270) | 2,905) | |
Current liabilities | 5,750) | 6,042) | 5,906) | 4,759) | 4,857) | |
Liquidity Ratio | ||||||
Cash ratio1 | 1.28 | 0.48 | 0.46 | 0.69 | 0.60 | |
Benchmarks | ||||||
Cash Ratio, Competitors2 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Cigna Group | — | — | — | — | — | |
CVS Health Corp. | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 7,361 ÷ 5,750 = 1.28
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Baxter International Inc. cash ratio improved from 2013 to 2014 and from 2014 to 2015. |